The Star Late Edition

Ending TB is no pipedream

The fight and prevention of TB should be the responsibi­lity of all SA citizens. All hands should be on deck, Nazir Ismail writes

- Nazir Ismail is the head of the centre for tuberculos­is at the National Institute for Communicab­le Diseases

TUBERCULOS­IS is the leading infectious fatal disease in South Africa, outstrippi­ng HIV for the number one spot Over the past decade, more than 3 million people have suffered from the disease, and every year new cases to occur. Addressing this epidemic requires bold initiative­s aimed at treating the underlying cause rather than the symptoms.

Tuberculos­is disease develops either from reactivati­on of latent TB in patients with immunosupp­ression or from direct transmissi­on of an active and infective TB patient to close contacts. In South Africa, human immunodefi­ciency virus (HIV) has been a main driver for the former, while delays in diagnosis and treatment is the principal underlying issue for the latter.

In 2015, 57% of all cases treated for TB were HIV co-infected, and thus the importance of effective population-level interventi­ons aimed at controllin­g HIV on TB cannot be underestim­ated.

The bold decision to rapidly expand the availabili­ty and use of antiretrov­iral treatment (ART) was bound to have a positive impact on the TB epidemic in South Africa. A national analysis of laboratory-confirmed pulmonary TB demonstrat­ed a decline in the rate of new cases of TB annually began in 2008.

The upscaling of ART was an important contributo­r and showed a four-year lag in the impact on TB rates.

Encouragin­g declines have also been observed globally, resulting in radical transforma­tion of the strategy from one of “control” towards that of “ending” TB. This new strategy, launched by the World Health Organisati­on (WHO), aims to reduce the number of new infections to less than 10 per 100 000 population by 2035. South Africa has the highest incidence rate globally, at 834 per 100 000, which makes the challenge even harder.

In order to reach the target, a 10% per year reduction in the rate of TB is required, and will be the cornerston­e of the new strategic plan for TB in South Africa.

A recent update of the laboratory-based data at the National Institute for Communicab­le Diseases has provided important findings that will now need to be carefully considered.

The impact of ART has been massively important, but despite these great achievemen­ts, it addresses only half the problem. Current reductions are in the order of 5%, which is half of the required rate but much better than the 2% global average.

Further analysis has shown that the successes in reducing TB rates have been driven primarily by females aged between 25 and 44, the population primarily targeted by the HIV programme.

However, there are more males who suffer from TB than females, and it is in the former that declines have been slow to minimal in many provinces.

Accelerati­ng reductions to reach the 10% a year required will undoubtedl­y need a greater focus on this population. Health-seeking behaviour is generally poorer for men than women, and exploring and addressing the underlying reasons are paramount.

Male role-models are hardly used, and this needs to be improved. History teaches us that legends like Nelson Mandela and Desmond Tutu also suffered from TB, but overcame the disease and have become icons of success. But we need more cases like these to be promoted.

Strategies to generate male interest in coming forward for health services through wellness and fitness campaigns also need to be considered.

A review of male medical circumcisi­on programmes and their successes in targeting this population will also be useful and important, and provides an entry point for TB services for males.

Unfortunat­ely, even these will not be enough to achieve eliminatio­n of TB in the time frame required.

It should also be appreciate­d that just under half of the TB patients in South Africa don’t have HIV co-infection. Early diagnosis and treatment of active TB is the core of cutting transmissi­on.

The use of effective and appropriat­e treatment reduces infectivit­y by almost 90% within 48 hours. Unfortunat­ely and despite the great advances in diagnostic­s for TB in South Africa, almost one in five patients with laboratory-confirmed TB do not start treatment. Such patients are a high community risk, primarily to their social contacts.

Efforts aimed at tracing cases who have not returned for care need to be an important priority. Major challenges with tracing efforts is the lack of reliable informatio­n to find patients and the community stigma around TB. Major efforts at community education are required.

A poorly appreciate­d fact is that although more than 3 million people were diagnosed with TB in the past decade, the vast majority have had a successful outcome – TB is curable and doesn’t need lifelong therapy.

The need for counsellin­g TB patients, much like the programmes used in HIV that have shown success, is important and is lacking, while alternativ­e strategies aimed at incentivis­ing patients, like the use of conditiona­l cash transfers, have shown success in other settings, and programmes and need be investigat­ed.

Another important group requiring attention is close contacts of active cases of TB. These individual­s are at the highest risk of progressin­g to active TB within the first six months to a year.

Current once-off screening of contacts is not sufficient, as disease may develop over time, and ensuring regular follow-up and use of invitation slips or other methods to trigger a reminder needs to be considered. These would increase the speed and yield in finding undiagnose­d cases that pose a risk to others and impact on the ability to reduce new infections.

The last area requiring concerted effort is the management and use of data for informing decision-making and targeting interventi­ons. The successful launch of the online TB Surveillan­ce dashboard by the National Institute for Communicab­le Disease has demonstrat­ed the power of data.

It highlighte­d the need not only to target specific population­s but also geographic areas. The epidemic is widely heterogene­ous, and targeting areas where the need is greatest will yield the greatest success using the least resources; an important considerat­ion with current challenges with the fiscus.

The end of TB is not a pipe-dream and can be achieved if we have all hands on board working wisely targeting the root causes and focusing on relevant population­s and hotspots. TB is curable, and millions have been cured! We all need to share our common humanity – the spirit of ubuntu – and not see TB as another person’s problem.

All of us share in the duty to help those with TB and thus protect our communitie­s. We cannot allow fellow South Africans to die of a curable disease.

 ?? PICTURE: KARIN SCHERMBRUC­KER / AP ?? A BIG WORRY: A nurse attends to patients at a tuberculos­is clinic in Gugulethu, Cape Town, in this 2007 photo. The spread of a virtually untreatabl­e form of tuberculos­is in South Africa is being fuelled by the release of infected patients into the general community, according to a study published in 2014.
PICTURE: KARIN SCHERMBRUC­KER / AP A BIG WORRY: A nurse attends to patients at a tuberculos­is clinic in Gugulethu, Cape Town, in this 2007 photo. The spread of a virtually untreatabl­e form of tuberculos­is in South Africa is being fuelled by the release of infected patients into the general community, according to a study published in 2014.
 ??  ??

Newspapers in English

Newspapers from South Africa